Skip to main content
Growth Hormone
Popular
99%+ Purity

Ipamorelin

Ipamorelin Acetate

Published: June 2, 2025 Last updated: June 23, 2025 Reviewed by MVP Peptides Editorial Team

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It is known for producing a clean growth hormone release without significantly affecting cortisol or prolactin levels, making it one of the safest GH-releasing peptides.

Buy Ipamorelin at Peptide Palace

Purity

99%+

Molecular Weight

711.85 g/mol

Administration

Subcutaneous injection

Storage

Store at -20°C

Mechanism of Action

Ipamorelin selectively binds to ghrelin receptors in the pituitary gland, triggering the release of growth hormone. Unlike other GHRPs, it does not significantly increase appetite, cortisol, acetylcholine, prolactin, or aldosterone.

Sequence:

Aib-His-D-2-Nal-D-Phe-Lys-NH2

Chemical Structure

Chemical structure of Ipamorelin

Research Areas

  • Growth hormone optimization
  • Body composition
  • Bone density
  • Anti-aging
  • Sleep improvement

Potential Benefits

  • Clean GH release
  • Minimal side effects
  • Improved sleep
  • Enhanced recovery
  • Better body composition

Research Dosing Guidelines

For research purposes only. Not for human consumption.

Typical Dose

100-300 mcg

Frequency

2-3 times daily

Duration

8-12 weeks

Administration

Subcutaneous injection, preferably before bed and upon waking

Best results when combined with CJC-1295 (no DAC) for synergistic GH release.

Reconstitution Calculator

mg
mcg
2.0 ml
0.5 ml5 ml

U-100 Insulin Syringe

0102030405060708090100

4.0 units

Concentration

2500 mcg/ml

Inject Volume

0.040 ml

Syringe Units

4.0 IU

Doses Per Vial

50

For research and educational purposes only. Always follow proper reconstitution and sterile handling protocols.

Ipamorelin vs GHRP-6: Choosing a Growth Hormone Secretagogue

Ipamorelin and GHRP-6 both trigger growth hormone release through the ghrelin receptor, but they differ dramatically in selectivity and side-effect profiles.

Head-to-Head Comparison

FactorIpamorelinGHRP-6
SelectivityHighly selective GH releaseNon-selective — raises cortisol, prolactin
Appetite effectMinimalSignificant increase
GH pulseClean, moderate pulseStronger but "dirtier" pulse
Best paired withCJC-1295 (no DAC)CJC-1295 (no DAC)
Side effectsMild headache, flushingHunger, water retention, cortisol spike
Best forAnti-aging, sleep, lean body compositionBulking, appetite stimulation, mass gain

For most research goals, Ipamorelin is the preferred choice due to its clean GH release profile. GHRP-6 remains relevant when appetite stimulation is a desired outcome, such as in muscle-wasting or underweight research models.

Potential Side Effects

  • Headache (mild)
  • Dizziness
  • Flushing
  • Injection site reactions

Storage Requirements

Store at -20°C. Reconstituted solution at 2-8°C for up to 4 weeks.

Research References

  • [1]
    Ipamorelin, a New Growth-Hormone-Releasing Peptide (1998)
    Emerging Evidence Population: Pentobarbital-anesthetized swine

    Ipamorelin selectively stimulated growth hormone release without affecting cortisol, prolactin, or ACTH levels in swine.

    Limitations: Animal model; anesthesia may affect hormonal responses

  • [2]
    Ipamorelin Induces Longitudinal Bone Growth in Rats (1999)
    Emerging Evidence Population: Female rats treated for 15 days

    Chronic ipamorelin treatment significantly increased longitudinal bone growth and body weight gain in rats.

    Limitations: Single animal species; juvenile growth model only

Frequently Asked Questions

What is Ipamorelin?

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist known for producing a clean growth hormone release. Unlike other GH-releasing peptides, it does not significantly affect cortisol or prolactin levels, making it one of the safest options in this class.

What are the potential research benefits of Ipamorelin?

Research indicates Ipamorelin may promote clean growth hormone release with minimal side effects, improve sleep quality, enhance recovery, and support better body composition. Its selective action on ghrelin receptors avoids the appetite-stimulating effects seen with other GHRPs.

How is Ipamorelin typically dosed in research?

Ipamorelin is typically administered at 100-300 mcg via subcutaneous injection, two to three times daily, preferably before bed and upon waking. Research cycles generally last 8-12 weeks, often in combination with CJC-1295 for synergistic effects.

What are the side effects of Ipamorelin?

Side effects of Ipamorelin are generally mild and may include headache, dizziness, flushing, and injection site reactions. It is considered one of the best-tolerated growth hormone secretagogues due to its selective receptor activity.

How should Ipamorelin be stored?

Ipamorelin should be stored at -20°C in lyophilized form. Once reconstituted, the solution should be kept at 2-8°C and can remain stable for up to four weeks.

Ready to Purchase Ipamorelin?

Get the highest quality Ipamorelin from our recommended vendor with 99%+ purity guaranteed.

Buy at Peptide Palace

Related Peptides

CJC-1295

CJC-1295 (with or without DAC)

CJC-1295 is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH), originally developed by ConjuChem Biotechnologies. It stimulates the pituitary gland to release growth hormone in a dose-dependent manner. It comes in two forms: with DAC (Drug Affinity Complex), which uses a maleimidopropionic acid linker to bind the peptide to serum albumin and extend its half-life to roughly 8 days, and without DAC (also called Mod GRF 1-29), which has a half-life of about 30 minutes and produces sharper, more natural GH pulses.

Learn More

GHRP-6

Growth Hormone Releasing Peptide-6

GHRP-6 is one of the first synthetic growth hormone releasing peptides. It strongly stimulates growth hormone release through the ghrelin receptor. It also notably increases appetite, which may be desirable or undesirable depending on research goals.

Learn More

Tesamorelin

Tesamorelin Acetate

Tesamorelin is a synthetic form of growth hormone-releasing hormone (GHRH). It is FDA-approved for reducing excess abdominal fat in HIV patients with lipodystrophy. It has become of interest for its ability to reduce visceral adipose tissue.

Learn More